1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine has been researched along with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in 9 studies
Studies (1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine) | Trials (1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine) | Recent Studies (post-2010) (1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine) | Studies (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) | Trials (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) | Recent Studies (post-2010) (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) |
---|---|---|---|---|---|
9 | 0 | 0 | 3,859 | 8 | 1,052 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (44.44) | 18.2507 |
2000's | 5 (55.56) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andrews, AM; Murphy, DL | 3 |
Andrews, AM; Cadet, JL; Epstein, CJ; Ladenheim, B; Murphy, DL | 1 |
Andrews, AM; Mazzola-Pomietto, P; Murphy, DL; Unger, EL | 1 |
Andrews, AM; Chisnell, AC; Luellen, BA; Miller, DB; Murphy, DL; O'Callaghan, JP | 1 |
Andrews, AM; Numis, AL; Szapacs, ME | 1 |
Andrews, AM; Chisnell, AC; Numis, AL; Sheridan, DL; Unger, EL | 1 |
Andrews, AM; Luellen, BA; Materese, CK; Szapacs, ME | 1 |
9 other study(ies) available for 1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Article | Year |
---|---|
Sustained depletion of cortical and hippocampal serotonin and norepinephrine but not striatal dopamine by 1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine (2'-NH2-MPTP): a comparative study with 2'-CH3-MPTP and MPTP.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain; Cerebral Cortex; Corpus Striatum; Dopamine; Dopamine Agents; Hippocampus; Male; Mice; Mice, Inbred C57BL; Norepinephrine; Serotonin; Tissue Distribution | 1993 |
Fluoxetine and desipramine selectively attenuate 2'-NH2-MPTP-induced depletions in serotonin and norepinephrine.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Body Temperature; Brain Chemistry; Carrier Proteins; Chromatography, High Pressure Liquid; Desipramine; Dose-Response Relationship, Drug; Fluoxetine; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Nerve Tissue Proteins; Neurotransmitter Uptake Inhibitors; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Symporters | 1993 |
2'-NH2-MPTP in Swiss Webster mice: evidence for long-term (6-month) depletions in cortical and hippocampal serotonin and norepinephrine, differential protection by selective uptake inhibitors or clorgyline and functional changes in central serotonin neuro
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Cerebral Cortex; Clorgyline; Desipramine; Fluoxetine; Hippocampus; Male; Mice; Monoamine Oxidase Inhibitors; MPTP Poisoning; Neurotransmitter Uptake Inhibitors; Norepinephrine; Paroxetine; Selegiline; Serotonin; Serotonin Receptor Agonists; Synaptic Transmission; Time Factors | 1993 |
Transgenic mice with high levels of superoxide dismutase activity are protected from the neurotoxic effects of 2'-NH2-MPTP on serotonergic and noradrenergic nerve terminals.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain; Humans; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Monoamine Oxidase; MPTP Poisoning; Nerve Endings; Norepinephrine; Serotonin; Superoxide Dismutase | 1996 |
2'-NH(2)-MPTP [1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine] depletes serotonin and norepinephrine in rats: a comparison with 2'-CH(3)-MPTP [1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine].
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Autoradiography; Body Temperature; Brain Chemistry; Carrier Proteins; Hydroxyindoleacetic Acid; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Norepinephrine; Piperazines; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Plasma Membrane Transport Proteins | 2002 |
Neuronal and astroglial responses to the serotonin and norepinephrine neurotoxin: 1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Astrocytes; Brain Chemistry; Dopamine; Enzyme-Linked Immunosorbent Assay; Glial Fibrillary Acidic Protein; Gliosis; Immunohistochemistry; Male; Mice; Neostriatum; Neurons; Neurotoxins; Norepinephrine; Serotonin; Silver Staining; Tyrosine 3-Monooxygenase | 2003 |
Late onset loss of hippocampal 5-HT and NE is accompanied by increases in BDNF protein expression in mice co-expressing mutant APP and PS1.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Age Factors; Amyloid beta-Protein Precursor; Animals; Brain-Derived Neurotrophic Factor; Corpus Striatum; Dopamine; Hippocampus; Humans; Male; Membrane Proteins; Mice; Mice, Inbred Strains; Mice, Transgenic; Norepinephrine; Presenilin-1; Serotonin | 2004 |
The role of membrane and vesicular monoamine transporters in the neurotoxic and hypothermic effects of 1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine (2'-NH(2)-MPTP).
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Body Temperature; Carrier Proteins; Gene Silencing; Hypothermia, Induced; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Knockout; MPTP Poisoning; Nerve Tissue Proteins; Neuropeptides; Serotonin; Serotonin Plasma Membrane Transport Proteins; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins | 2004 |
The neurotoxin 2'-NH2-MPTP degenerates serotonin axons and evokes increases in hippocampal BDNF.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Analysis of Variance; Animals; Axons; Biogenic Monoamines; Brain Chemistry; Brain-Derived Neurotrophic Factor; Chromatography, High Pressure Liquid; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation; Hippocampus; Immunohistochemistry; Male; Mice; Nerve Degeneration; RNA, Messenger; Serotonin; Time Factors; Tyrosine 3-Monooxygenase | 2006 |